Previous reports demonstrated a relationship between proliferation potential and trilineage differentiation in mesenchymal stromal cells-derived clones generated using plastic adherence (PA-MSCs). However, there are no reports presenting a clonal analysis of the proliferative potential, differentiation potential and allosuppressive effects of human mesenchymal stromal cell subsets. In this study, we perfomed a clonal analysis of mesenchymal stromal cells generated from human In conclusion, our findings demonstrate differences between CD271-MSCs and PAMSCs and indicate that neither proliferation potential nor differentiation potential represents a consistent predictive parameter for the immunomodulatory effects of either type of mesenchymal stromal cells.
Introduction
Mesenchymal stromal cells (MSCs) represent a very heterogeneous population of multipotent progenitor cells with a varying proliferative, differentiation and immunosuppressive potential. 1 The majority of the available evidence concerning the functional heterogeneity of MSCs has been obtained from clonal studies. Muraglia et al. 2 reported that only one third of the MSC-clones generated from bone marrow mononuclear cells were able to differentiate into adipocytes, osteoblasts and chondrocytes (trilineage potential). Likewise, Lee et al. 3 assessed adult human bone marrow MSCs at a single-cell level and found that only 7% of MSCs, which demonstrated a high proliferative potential, were able to differentiate toward multiple lineages. Most recently, Russell et al. 4 reported that tripotent MSCs accounted for nearly 50% of the colony-forming cells. Another study using single-cell derived clones from parental immortalized MSCs demonstrated the presence of tri-, bi-, and unidirectional clones, suggesting that MSCs are constituted by a group of cells with different differentiation potential. 5 The relationship between proliferation and trilineage potential has been also addressed using MSCs derived from tissue sources other than bone marrow. Guilak et al. 6 reported that of clones generated from human adipose tissue-derived stromal cells, 21% were tripotent, 31% were bipotent and 29%
were unipotent MSCs. In addition, clonal analysis of bone marrow stromal cells from three patients with the degenerative disease osteoarthritis (OA) demonstrated the presence of fast-growing and slow-growing clones. All but one of the fast-growing clones were tripotent, whereas slow-growing clones displayed limited differentiation and morphological changes associated with cellular senescence.
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However, none of these studies has investigated the relationship between the proliferative and allosuppressive potential at the clonal level for PA-MSCs or any other subset of MSCs. In a previous study we demonstrated that an MSC-subset generated from CD271 + bone marrow mononuclear cells (CD271-MSCs) was able to effectively suppress the allogeneic reaction even at low concentrations. 8 In this study, we attempted to gain additional insight into the proliferative, differentiation and allosuppressive potential of this MSC-subset at the clonal level, including the molecular mechanisms involved in this process.
Methods
Additional details on the design and methods of this study are provided in the Online Supplement.
Immunomagnetic selection of CD271 + bone marrow mononuclear cells and generation of CD271-mesenchymal stromal cells BM-MNCs were obtained from the bone marrow aspirates of three healthy donors using a protocol approved by the University of Frankfurt Institutional Review Board.
Briefly, two volumes of diluted bone marrow aspirate with PBS (1:2) were layered over one volume Ficoll (density: 1,073 g/ml GE Healthcare, Uppsala, Sweden) and centrifuged at 700 x g for 30 min without brake. Mononuclear cells were collected from the interface, washed twice with PBS and centrifuged at 400 x g for 10 min. One proportion of the mononuclear cells was used for generation of PA-MSCs and the other portion of mononuclear cells was used for generation of CD271-MSCs, as described elsewhere.
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Evaluation of the immunosuppressive potential of MSC-derived clones
To test the immunosuppressive effect of CD271-MSC and PA-MSC derived clones on the alloantigen-driven reaction, we used mixed lymphocyte reaction (MLR).
Peripheral blood mononuclear cells (PB-MNCs) from healthy unrelated donors were isolated using a Ficoll-gradient (density 1.077, Biochrom KG, Berlin, Germany), washed twice with PBS and resuspended in RPMI-1640 with 10% FBS (Invitrogen). 
Statistical analysis
The statistical significance was assessed using Prism 5 software (GraphPad Software, San Diego, CA, USA). The Mann-Whitney U test was used to compare two independent samples, whereas Spearman's rank correlation coefficient was used to correlate variables. The P values less than 0.05 and r values greater than 0.6 were considered statistically significant.
Results
Clonogenic, differentiation and proliferation potential of single-cell-derived
CD271-MSC clones
In this study we asked whether MSCs generated from positively selected CD271 Figure 2C ). We observed that 68±7.8% of single-sorted CD271-MSCs from passage 2 generated CFU-Fs, compared to 43.1±0.5% of PA-MSCs (P<0.04) ( Figure   2D ). All of the clonally derived CD271-MSCs were negative for CD45 and CD34, but they were positive for classical MSC-antigens (CD73, CD90 and CD105) and class I HLA antigens ( Figure 2E ). In addition to these antigens, we assessed the expression of the STRO-1 antigen and CD146, which are cell surface markers used for the prospective isolation of MSCs from the bone marrow. We found that neither CD271-MSC nor PA-MSC derived clones expressed these antigens ( Figure 2E ). Figure 4C ). In addition, the time in culture needed for duplication (doubling time) was shorter for CD271-MSCs clones (1.89 ± 0.07 days) than for PA-MSCs clones (1.98 ± 0.06 days) ( Figure 4D ), but this difference was not statistically significant.
Immunosuppressive properties of CD271-MSC clones
As were associated with the higher PGE2 levels than 10 ng/ml, while low-suppressive clones (less than 40% of MLR inhibition) had PGE2 levels less than 10 ng/ml ( Figure   6A ). To identify other mediators in partially PGE2-dependent and PGE2-independent clones, we used a highly specific IDO-inhibitor (CAY10581) in order to investigate the role of IDO in the observed alloantigen-driven suppression. Our results demonstrate that the IDO-inhibitor was unable to reverse the allosuppressive effect of clones
Remarkably, the mean allosuppressive potential of non-cloned CD271-MSCs generated from two bone marrow donors that were used for generation of clones ( Figure 6E ), was nearly the same (60%) as the mean of allosuppressive potential of individual clones generated from these MSCs ( Figure 5A ). This allosuppressive effect was only partially reversed by the PGE2 synthesis inhibitor indomethacin ( Figure 6E) and was associated with a significant increase (P<0.0006) in PGE2 levels ( Figure   6F ). A similar pattern was observed for the PA-MSC derived clones (data not shown).
Trilineage differentiation potential of clones and its relationship to the allosuppressive effect.
In this study, we asked whether CD271-MSC derived clones possess trilineage differentiation potential. We differentiated 15 clones derived from CD271-MSCs and 10 clones derived from PA-MSCs (Online Supplementary Methods). We found that 13.3% of these clones were tripotent, with the ability to differentiate into adipocytes, Numerous reports demonstrated that CD271-MSCs have a significantly higher proliferative potential than PA-MSCs. 14, 15 We asked whether this functional property of CD271-MSCs could be confirmed at the clonal level. CD271-MSCs from passage 2 gave rise to a significantly higher number of CFU-Fs than PA-MSCs (P<0.04),
indicating that these MSCs have a higher clonogenic potential, as has been previously reported for the whole population of CD271-MSCs. 9, 14 Proliferative studies presented here also demonstrated that a significantly higher number of clones (25%)
derived from CD271-MSCs were highly proliferative than clones (10%) derived from PA-MSCs. The percentage of highly proliferative clones generated from CD271-MSCs was similar to the number of clones generated from PA-MSCs, as reported by Muraglia et al. 2 In addition, the number of highly proliferative clones generated from PA-MSCs in our study was consistent with the findings of Lee et al. 
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Legend to Figures
Immunocytochemistry of MSC-derived clones
To assess the expression of tissue-specific antigens on clonally derived GFP-positive 
Determination of prostaglandin E2 and IDO in the supernatants of MLR
We used the experimental design described above for the BrdU assay to generate an identical set of MLRs in a second 96-well plate for the collection of supernatants for quantification of the soluble molecules PGE2 and IDO. On day 7 supernatants were collected, centrifuged at 14000 x g for 5 minutes to remove cell debris and then frozen at -80 °C until the time of the assay. PGE2 levels in the in the MLR supernatants were determined after diluting them 1:32, according to the manufacturer's instructions (Biomol GmbH, Hamburg, Germany). To quantify IDO levels, supernatants from the wells without MSCs were diluted 1:50, and supernatants from the wells containing PB-MNCs and MSCs were diluted 1:200. IDO levels were quantified using the ELISA-kit according to the manufacturer's instructions (Biozol, Eching, Germany). 
Supplementary Figure 1
A
Supplementary Figure 2
In order to assess whether the MSCs of passage 1 that were used for clonal studies are multipotent we cultured both CD271-MSCs (A) and PA-MSCs (B) of CD271-MSCs of passage 1 in induction media for adipocytes, osteoblasts and chondrocytes. On day 10 osteoblasts can be identified by their cuboidal apparence and their association with newly synthesized new bone matrix. Furthemore, committed osteogenic cells are characterized by expression of high levels of alkaline phosphatase, an enzyme that is involved in the bone matrix mineralization. After 2-3 weeks, lipid vacuoles started to appear and on day 21 the developed adipocytes were stained with Oil Red O solution. In the chondrocytic induction medium the MSCs gave rise to a nodular micromass, which was fixed on day 24 in 4% paraformaldehyde, parafinized and then cut with the microtome in 5 µm thick sections. These slides were stained with alcian blue, which stains acidic polysaccharides such as glycosaminoglycans in cartilage. Magnification for microphotographs of adipocytes was 20X, for osteoblasts 10x and for chondrocytes was 40x.
